C07D 285/10
1,2,5-thiadiazoles
Official title: 1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
C07D285/10 (1,2,5-thiadiazoles) appears on 271 US grants and 158 published applications in this corpus.
Search patents in C07D- Granted patents
- 271
- Published applications
- 158
- Assignees
- 158
- Inventors
- 728
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 4 | 0 |
| 1978 | 4 | 0 |
| 1979 | 5 | 0 |
| 1980 | 0 | 0 |
| 1981 | 5 | 0 |
| 1982 | 4 | 0 |
| 1983 | 5 | 0 |
| 1984 | 7 | 0 |
| 1985 | 15 | 0 |
| 1986 | 12 | 0 |
| 1987 | 13 | 0 |
| 1988 | 8 | 0 |
| 1989 | 6 | 0 |
| 1990 | 5 | 0 |
| 1991 | 6 | 0 |
| 1992 | 1 | 0 |
| 1993 | 7 | 0 |
| 1994 | 5 | 0 |
| 1995 | 5 | 0 |
| 1996 | 12 | 0 |
| 1997 | 5 | 0 |
| 1998 | 5 | 0 |
| 1999 | 5 | 0 |
| 2000 | 5 | 0 |
| 2001 | 10 | 2 |
| 2002 | 8 | 7 |
| 2003 | 6 | 6 |
| 2004 | 5 | 17 |
| 2005 | 6 | 8 |
| 2006 | 6 | 8 |
| 2007 | 7 | 8 |
| 2008 | 7 | 11 |
| 2009 | 3 | 3 |
| 2010 | 11 | 12 |
| 2011 | 4 | 4 |
| 2012 | 4 | 2 |
| 2013 | 3 | 3 |
| 2014 | 6 | 10 |
| 2015 | 5 | 3 |
| 2016 | 3 | 4 |
| 2017 | 1 | 4 |
| 2018 | 2 | 3 |
| 2019 | 2 | 3 |
| 2020 | 4 | 6 |
| 2021 | 6 | 5 |
| 2022 | 3 | 5 |
| 2023 | 1 | 4 |
| 2024 | 4 | 10 |
| 2025 | 2 | 7 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- 1,2,5-thiadiazolidin-3-one 1,1-dioxide containing compounds and uses thereof23 Dec 2025US 12,503,464 B2Kumquat Biosciences Inc.
- Compounds and methods for treating oxalate-related diseases4 Feb 2025US 12,213,976 B2OxaluRx, Inc.
- Inhibitors of protein tyrosine phosphatase, compositions, and methods of use10 Dec 2024US 12,162,848 B2Bristol-Myers Squibb Company
- Small molecule compounds having naphthylamine structure and application thereof26 Nov 2024US 12,151,999 B2Hangzhou PhecdaMed Co., Ltd.
- Heterocyclic compounds and uses thereof23 Apr 2026US 2026/0109694 A1Kumquat Biosciences Inc.
- Inhibitors of protein tyrosine phosphatase, compositions, and methods of use8 Jan 2026US 2026/0008777 A1Bristol-Myers Squibb Company
- Compound, electrolyte for rechargeable lithium battery including the same, and rechargeable lithium battery including the same8 Jan 2026US 2026/0011782 A1Samsung SDI.Co., Ltd.
- Heterocyclic compounds and uses thereof25 Sep 2025US 2025/0296927 A1Kumquat Biosciences Inc.
- Protein tyrosine phosphatase inhibitors and uses thereof14 Aug 2025US 2025/0257059 A1Nerio Therapeutics, Inc.
Most cited
By later US patents
- (Acyloxyalkoxy)carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs119US 4,760,057 AMerck & Co., Inc. · 1988
- Anti-inflammatory medicaments104US 7,202,257 B2Deciphera Pharmaceuticals, LLC · 2007
- Anti-inflammatory medicaments83US 7,342,037 B2Deciphera Pharmaceuticals, LLC · 2008
- Anti-inflammatory medicaments81US 7,531,566 B2Deciphera Pharmaceuticals, LLC · 2009
- Composition for treating pain79US 5,998,434 AEli Lilly and Company · 1999